{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:05:07Z","timestamp":1787951107816,"version":"build-2784847793"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"crossref","award":["No. 7202047"],"award-info":[{"award-number":["No. 7202047"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Capital's Funds for Health Improvement and Research","award":["No. 2020-2-2112"],"award-info":[{"award-number":["No. 2020-2-2112"]}]},{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals\u2019 Ascent Plan","doi-asserted-by":"crossref","award":["DFL20181401"],"award-info":[{"award-number":["DFL20181401"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To investigate abnormalities of early folliculogenesis and Anti-M\u00fcllerian hormone (AMH) concentrations in polycystic ovary syndrome (PCOS) patients, and to analyze the association between AMH and early-stage follicle densities (FD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 175 patients underwent ovarian tissue cryopreservation in the first official cryobank in China, of which 16 patients aged 30\u201340 years old were diagnosed with endometrial cancer (all without initial chemo\/radiotherapy), including 5 patients with concurrent PCOS and the other 11 patients without. We obtained standard cortical biopsies to measure FD using calcein staining. Blood samples were collected before cryopreservation to evaluate AMH concentrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      PCOS showed nearly three times the primordial and primary FD than NPCOS (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.027), as well as more secondary preantral follicles (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002). A significantly higher proportion of secondary preantral follicles and a lower proportion of primordial and primary follicles were observed in PCOS (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.01). Furthermore, the AMH concentration in PCOS was four times higher than that in NPCOS (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003), which is significantly correlated with primordial and primary follicle densities (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.855,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and secondary preantral follicle densities (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.732,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.007).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We found significant disorders of early folliculogenesis in PCOS, which showed close correlation with increased AMH concentrations. To our knowledge, abnormalities of early-stage follicles have been shown for the first time in ovarian tissue of Chinese PCOS women. We suppose that the elevated AMH level is associated with abnormalities of early folliculogenesis within the complex PCOS pathogenesis, which may explain why AMH has the potential to be used as a biomarker for the diagnosis of PCOS. Our findings provide more implications for understanding the mechanism of PCOS, and new directions for further studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13048-021-00786-0","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T11:02:26Z","timestamp":1613818946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Abnormalities of early folliculogenesis and serum anti-M\u00fcllerian hormone in chinese patients with polycystic ovary syndrome"],"prefix":"10.1186","volume":"14","author":[{"given":"Juan","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7777-247X","authenticated-orcid":false,"given":"Xiangyan","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanglu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muqing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred Otto","family":"Mueck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"issue":"9","key":"786_CR1","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602\u201318.","journal-title":"Hum Reprod"},{"key":"786_CR2","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"786_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10815-019-01622-7","volume":"37","author":"J Bedenk","year":"2020","unstructured":"Bedenk J, Vrtacnik-Bokal E, Virant-Klun I. The role of anti-Mullerian hormone (AMH) in ovarian disease and infertility. J Assist Reprod Genet. 2020;37(1):89\u2013100.","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"786_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.fertnstert.2016.04.040","volume":"106","author":"MR Jones","year":"2016","unstructured":"Jones MR, Goodarzi MO. Genetic determinants of polycystic ovary syndrome: progress and future directions. Fertil Steril. 2016;106(1):25\u201332.","journal-title":"Fertil Steril"},{"issue":"8","key":"786_CR5","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.steroids.2013.04.006","volume":"78","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Qiao J. Ethnic differences in the phenotypic expression of polycystic ovary syndrome. Steroids. 2013;78(8):755\u201360.","journal-title":"Steroids"},{"issue":"9","key":"786_CR6","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1093\/humrep\/det262","volume":"28","author":"R Li","year":"2013","unstructured":"Li R, Zhang Q, Yang D, et al. Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod. 2013;28(9):2562\u20139.","journal-title":"Hum Reprod"},{"issue":"9389","key":"786_CR7","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S0140-6736(03)14410-8","volume":"362","author":"LJ Webber","year":"2003","unstructured":"Webber LJ, Stubbs S, Stark J, et al. Formation and early development of follicles in the polycystic ovary. Lancet. 2003;362(9389):1017\u201321.","journal-title":"Lancet"},{"issue":"12","key":"786_CR8","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1210\/jc.2019-01094","volume":"104","author":"SG Kristensen","year":"2019","unstructured":"Kristensen SG, Kumar A, Kalra B, et al. Quantitative Differences in TGF-beta Family Members Measured in Small Antral Follicle Fluids From Women With or Without PCO. J Clin Endocrinol Metab. 2019;104(12):6371\u201384.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"786_CR9","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/humupd\/dmu020","volume":"20","author":"SL Broer","year":"2014","unstructured":"Broer SL, Broekmans FJ, Laven JS, et al. Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update. 2014;20(5):688\u2013701.","journal-title":"Hum Reprod Update"},{"issue":"12","key":"786_CR10","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1093\/humrep\/dez215","volume":"34","author":"J Liebenthron","year":"2019","unstructured":"Liebenthron J, Reinsberg J, van der Ven K, et al. Serum anti-Mullerian hormone concentration and follicle density throughout reproductive life and in different diseases-implications in fertility preservation. Hum Reprod. 2019;34(12):2513\u201322.","journal-title":"Hum Reprod"},{"issue":"6","key":"786_CR11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/humupd\/dmw027","volume":"22","author":"D Dewailly","year":"2016","unstructured":"Dewailly D, Robin G, Peigne M, et al. Interactions between androgens, FSH, anti-Mullerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary. Hum Reprod Update. 2016;22(6):709\u201324.","journal-title":"Hum Reprod Update"},{"key":"786_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejogrb.2016.01.029","volume":"199","author":"X Qi","year":"2016","unstructured":"Qi X, Pang Y, Qiao J. The role of anti-Mullerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2016;199:82\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"786_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12958-015-0134-9","volume":"13","author":"A Dumont","year":"2015","unstructured":"Dumont A, Robin G, Catteau-Jonard S, et al. Role of Anti-M\u00fcllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review. Reprod Biol Endocrinol. 2015;13:137.","journal-title":"Reprod Biol Endocrinol"},{"issue":"11","key":"786_CR14","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3109\/09513590.2014.943719","volume":"30","author":"X Tian","year":"2014","unstructured":"Tian X, Ruan X, Mueck AO, et al. Serum anti-M\u00fcllerian hormone and insulin resistance in the main phenotypes of non-obese polycystic ovarian syndrome women in China. Gynecol Endocrinol. 2014;30(11):836\u20139.","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"786_CR15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3109\/09513590.2013.864273","volume":"30","author":"X Tian","year":"2014","unstructured":"Tian X, Ruan X, Mueck AO, et al. Anti-M\u00fcllerian hormone levels in women with polycystic ovarian syndrome compared with normal women of reproductive age in China. Gynecol Endocrinol. 2014;30(2):126\u20139.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"786_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.rbmo.2016.04.007","volume":"33","author":"D Garg","year":"2016","unstructured":"Garg D, Tal R. The role of AMH in the pathophysiology of polycystic ovarian syndrome. Reprod Biomed Online. 2016;33(1):15\u201328.","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"786_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13048-019-0521-5","volume":"12","author":"X Ruan","year":"2019","unstructured":"Ruan X, Cui Y, Du J, et al. Randomized study to prove the quality of human ovarian tissue cryopreservation by xenotransplantation into mice. J Ovarian Res. 2019;12(1):46.","journal-title":"J Ovarian Res"},{"issue":"1","key":"786_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"ESHRE\/ Rotterdam","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u20137.","journal-title":"Hum Reprod"},{"issue":"2","key":"786_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1210\/edrv-17-2-121","volume":"17","author":"A Gougeon","year":"1996","unstructured":"Gougeon A. Regulation of Ovarian Follicular Development in Primates. Endocr Rev. 1996;17(2):121\u201355.","journal-title":"Endocr Rev"},{"key":"786_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-3-319-31973-5_7","volume":"58","author":"N Rimon-Dahari","year":"2016","unstructured":"Rimon-Dahari N, Yerushalmi-Heinemann L, Alyagor L, et al. Ovarian Folliculogenesis Results Probl Cell Differ. 2016;58:167\u201390.","journal-title":"Results Probl Cell Differ"},{"key":"786_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.maturitas.2020.02.001","volume":"134","author":"M von Wolff","year":"2020","unstructured":"von Wolff M, Roumet M, Stute P, et al. Serum anti-Mullerian hormone (AMH) concentration has limited prognostic value for density of primordial and primary follicles, questioning it as an accurate parameter for the ovarian reserve. Maturitas. 2020;134:34\u201340.","journal-title":"Maturitas"},{"issue":"11","key":"786_CR22","doi-asserted-by":"publisher","first-page":"5321","DOI":"10.1210\/jc.2004-0643","volume":"89","author":"GA Maciel","year":"2004","unstructured":"Maciel GA, Baracat EC, Benda JA, et al. Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89(11):5321\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"786_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mce.2012.07.011","volume":"373","author":"RJ Chang","year":"2013","unstructured":"Chang RJ, Cook-Andersen H. Disordered follicle development. Mol Cell Endocrinol. 2013;373(1\u20132):51\u201360.","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"786_CR24","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1210\/jc.2006-1422","volume":"92","author":"LJ Webber","year":"2007","unstructured":"Webber LJ, Stubbs SA, Stark J, et al. Prolonged survival in culture of preantral follicles from polycystic ovaries. J Clin Endocrinol Metab. 2007;92(5):1975\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"786_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1530\/rep.1.01074","volume":"132","author":"PG Knight","year":"2006","unstructured":"Knight PG, Glister C. TGF-beta superfamily members and ovarian follicle development. Reproduction. 2006;132(2):191\u2013206.","journal-title":"Reproduction"},{"issue":"1","key":"786_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jogoh.2018.10.015","volume":"48","author":"M Victoria","year":"2019","unstructured":"Victoria M, Labrosse J, Krief F, et al. Anti Mullerian Hormone: More than a biomarker of female reproductive function. J Gynecol Obstet Hum Reprod. 2019;48(1):19\u201324.","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"7","key":"786_CR27","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.tem.2019.04.006","volume":"30","author":"H Teede","year":"2019","unstructured":"Teede H, Misso M, Tassone EC, et al. Anti-Mullerian Hormone in PCOS: A Review Informing International Guidelines. Trends Endocrinol Metab. 2019;30(7):467\u201378.","journal-title":"Trends Endocrinol Metab"},{"issue":"11","key":"786_CR28","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s10815-014-0328-7","volume":"31","author":"DB Seifer","year":"2014","unstructured":"Seifer DB, Merhi Z. Is AMH a regulator of follicular atresia? J Assist Reprod Genet. 2014;31(11):1403\u20137.","journal-title":"J Assist Reprod Genet"},{"issue":"5","key":"786_CR29","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.fertnstert.2020.07.007","volume":"114","author":"DI Dozortsev","year":"2020","unstructured":"Dozortsev DI, Pellicer A, Diamond MP. Premature progesterone rise as a trigger of polycystic ovarian syndrome. Fertil Steril. 2020;114(5):943\u20134.","journal-title":"Fertil Steril"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-021-00786-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13048-021-00786-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-021-00786-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T11:06:29Z","timestamp":1613819189000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-021-00786-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["786"],"URL":"https:\/\/doi.org\/10.1186\/s13048-021-00786-0","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,18]]},"assertion":[{"value":"26 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by our hospital ethics committee (NO. 2017-KY-020-01).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}